Yogesh Bansod

Yogesh Bansod

Auto-generated profile, based on publicly available information

Yogesh Bansod

Division of Colorectal Oncology, Department of Surgical Oncology Tata Memorial Centre Mumbai India

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 March 2025 in Cancer Reports
Verified
Journal Article
Open access
JMJoseph Mathew
Joseph Mathew
YBYogesh Kisan Bansod
Yogesh Kisan Bansod
NYNishant Yadav
Nishant Yadav
JMJanesh Murugan
Janesh Murugan
KRKovvuru Bhaskar Reddy
Kovvuru Bhaskar Reddy
ASAvanish Saklani
Avanish Saklani
Background: Robotic surgery has been associated with superior short‐term outcomes in patients undergoing total mesorectal excision (TME) for organ‐confined rectal cancer. However, whether this approach offers an additional benefit over laparoscopy when performing lateral pelvic lymph node dissection (LPLND) with TME or extended TME (e‐TME) in locally advanced rectal cancer (LARC) is not known.Aims: This study was conducted to evaluate the outcomes of robotic and laparoscopic LPLND in patients with lateral pelvic node‐positive LARC with reference to intraoperative safety, postoperative morbidity, pathological indices including nodal yield and node positivity rates, lateral pelvic recurrence rates, and short term event‐free and overall survival.Methods and Results: In this retrospective single‐center study, consecutive patients with non‐metastatic histologically proven LARC and clinically significant lateral pelvic lymphadenopathy who had undergone laparoscopic or robotic LPLND with TME or e‐TME between 2014 and 2023 were included, all procedures having been performed by minimal‐access colorectal surgeons who were beyond the learning curve for either surgical approach. Of the 115 patients evaluated, 98.3% received neoadjuvant chemoradiotherapy, following which 27 (23.5%) underwent robotic and 88 (76.5%) laparoscopic LPLND with TME or e‐TME. The baseline clinicodemographic features, treatment‐related characteristics, and proportion of patients undergoing extended resections for persistent circumferential resection margin‐positive rectal cancer (22.7% vs. 18.5%, respectively) were statistically similar in both groups. When comparing robotic with laparoscopic resections, no significant difference was observed in intraoperative parameters including procedure‐associated blood loss (median 250 mL vs. 400 mL) and on‐table adverse events or conversion rates (none in either group), postoperative outcomes comprising clinically significant early (14.8% vs. 9.1%), intermediate (5.3% vs. 1.9%) and late (5.3% vs. 2.0%) surgical morbidity, re‐exploration rates (7.4% vs. 3.4%) and duration of hospital stay (median 6 days in both groups), or the pathological quality indices of margin involvement (7.4% vs. 2.3%), nodal yield (median 4 vs. 7 nodes) and lateral node positivity (22.2% vs. 26.1%), respectively. At a median 11 months follow‐up, oncological outcomes in terms of lateral pelvic recurrence rates (3.7% vs. 4.5%), 2‐year event‐free survival (78.7% vs. 79.3%) and 2‐year overall survival (83.1% vs. 93.8%) were also comparable.Conclusion: Surgical competence in laparoscopy may offset the potential benefits extended by robotic platforms. In a high‐volume setup with experienced minimal‐access surgeons, the clinical, pathological, and short‐term oncological outcomes associated with both approaches may be considered equivalent.

12 November 2024 in Colorectal Disease
Verified
Journal Article
Open access
DBDevesh S. Ballal
Devesh S. Ballal
ASAnkit Sharma
Ankit Sharma
YBYogesh Bansod
Yogesh Bansod
SASuman K. Ankathi
Suman K. Ankathi
Mufaddal KaziMufaddal Kazi
Mufaddal Kazi
ASAvanish Saklani
Avanish Saklani
Background: Extramural vascular invasion (EMVI) is a bad prognostic feature in rectal cancer and cancers that remain EMVI positive after neoadjuvant therapy are at high risk for having involved circumferential resection margins. Conventional total mesorectal excision (TME) resections are inadequate in such cases and often lead to positive margins.Methods: We propose a technique for the surgical management of locally advanced tumours with persistent EMVI after neoadjuvant therapy. Ten such tumours were resected using a “beyond TME” (b‐TME) approach with or without lateral pelvic lymph node dissection or seminal vesical excision.Results: A b‐TME approach, customized to the anatomy of the tumour allowed for an R0 resection with a negative circumferential resection margin (CRM) in all 10 cases.Conclusion: A tailored b‐TME approach can achieve good results in cases at high risk for CRM involvement.

6 October 2025 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
YBYogesh Bansod
Yogesh Bansod
ADAshwin L. Desouza
Ashwin L. Desouza
ASAvanish Saklani
Avanish Saklani

7 February 2025 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
YBYogesh M.S. Bansod
Yogesh M.S. Bansod
ADAshwin M.S. Desouza
Ashwin M.S. Desouza
ASAvanish Saklani
Avanish Saklani
An abstract is unavailable. This article is available as a PDF only.

20 October 2023 in Colorectal Disease
Verified
Journal Article
Closed access
SBSanket Bankar
Sanket Bankar
YBYogesh Bansod
Yogesh Bansod
PRPrudvi Raj
Prudvi Raj
Mufaddal KaziMufaddal Kazi
Mufaddal Kazi
ADAshwin DeSouza
Ashwin DeSouza
ASAvanish Saklani
Avanish Saklani

13 July 2024 in Diseases of the Colon & Rectum
Verified
Journal Article
Closed access
YBYogesh M.S. Bansod
Yogesh M.S. Bansod
ADAshwin M.S. Desouza
Ashwin M.S. Desouza
ASAvanish Saklani
Avanish Saklani
An abstract is unavailable. This article is available as a PDF only.